Search

Search Constraints

You searched for: Author/Creator Maurer, Mathew

Search Results

4. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 10253 (12th September 2020)

5. Mechanical Circulatory Support Device Utilization and Heart Transplant Waitlist Outcomes in Patients With Restrictive and Hypertrophic Cardiomyopathy. (March 2018)

6. Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis. Issue 1 (June 2016)

9. Phase 2, open-label extension (OLE) study of revusiran, an investigational RNAi therapeutic for the treatment of patients with transthyretin cardiac amyloidosis. Issue 1 (December 2015)

10. Recommendations from the Amyloidosis Research Consortium Educational Roundtable at the American College of Cardiology Annual Meeting, 1 April 2016. (16th March 2017)